In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells. [electronic resource]
- PLoS pathogens 2012
- e1002649 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1553-7374
10.1371/journal.ppat.1002649 doi
Animals CD8-Positive T-Lymphocytes--immunology Cell Engineering Female Genetic Therapy HIV Core Protein p24--genetics HIV Infections--genetics HIV-1--physiology Hematopoietic Stem Cell Transplantation Hematopoietic Stem Cells--immunology Humans Male Mice Mice, Transgenic Receptors, Antigen, T-Cell--genetics Transplantation, Heterologous Virus Replication--physiology